Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib PK/PD Study in Japanese and Caucasian Healthy Subjects
NCT02162355Phase 1Completed
- Sponsor
- Galapagos NV
- Start
- Jun 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of filgotinib in rheumatoid arthritis (RA) (6 arms), sponsored by Galapagos NV. Primary endpoints: Number of subjects with adverse events, Number of subjects with abnormal laboratory parameters and 3 more. Started Jun 2014; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02162355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162355.